Castor EDC: Unlocking the Potential of Data in Biomedical Research

Projektinformationen

Castor EDC

ID Finanzhilfevereinbarung: 767814

DOI 10.3030/767814

Abgeschlossenes Projekt

EK-Unterschriftsdatum 18 Mai 2017

Startdatum 1 April 2017

Enddatum 31 März 2019

Finanziert unter

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)

Gesamtkosten € 1 547 500,00

EU-Beitrag € 1 083 250,00

Koordiniert durch

CIWIT BV
Netherlands

Ziel

A large part of the data collected during the biomedical research is wasted, because there is no affordable and easy-to-use Electronic Data Capture (EDC) tool for clinical trials. As a result, 85% of the research investment in the biomedical research domain – equating to $200 billion – is dissipated. Castor is a disruptive EDC that solves this problem. It has been successfully commercialized to 5,000 users in the Netherlands, especially in the academic sector. In terms of price and functionalities, Castor EDC is tailored to the needs SMEs performing medical research (e.g. Commercial Research Organizations working on drug development and SMEs manufacturing medical devices/wearables) and academic institutions; these segments are neglected by the existing commercial EDC platforms, which mainly target the needs of pharmaceutical corporations. This market is enormous (over €1.7B globally) and growing quickly due to the recent EU regulations on sensitive data protection. Castor EDC is also the first EDC complying with the FAIR guidelines for data collection, which will become the standard de facto within a couple of years.
Thanks to these characteristics, data sets can now be easily shared across researchers and reused, thus unlocking the potential of data of biomedical studies. This will help to overcome the current fragmentation of the European databases that has led to lost opportunities when making sense of big data in health research.
This innovation project has two main objectives. First, upgrading the existing tool to TRL 9, by enhancing with advanced functionalities the Electronic Data Capture tool and integrate it with i) a platform that facilitates researchers in sharing and reusing their datasets and ii) a marketplace where 3rd party developers can offer additional services to work on those datasets. Second, carry out the planned exploitation activities to establish Castor EDC as a EU-28 market leader in the market within 3 years from the end of the project.

Wissenschaftliches Gebiet

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• natural sciences › computer and information sciences › computer security › data protection
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• natural sciences › computer and information sciences › data science › big data
• social sciences › sociology › industrial relations › automation

Programm/Programme

• H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• SMEInst-01-2016-2017 - Open Disruptive Innovation Scheme

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2016-2017

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-2-2016-2017

Finanzierungsplan

SME-2 - SME instrument phase 2

Koordinator

CIWIT BV

• Netto-EU-Beitrag: € 1 083 250,00
• Adresse: PAASHEUVELWEG 25 ; 1105 BP AMSTERDAM ; Niederlande
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  West-Nederland › Noord-Holland › Groot-Amsterdam
• Region: West-Nederland › Noord-Holland › Groot-Amsterdam
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 1 547 500,00